Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue
- PMID: 33106586
- DOI: 10.1038/s41385-020-00351-w
Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue
Abstract
Type 2 innate lymphoid cells (ILC2s) play a critical role early in the response to infection by helminths and in the development of allergic reactions. ILC2s are also involved in the physiologic regulation of adipose tissue and its metabolic response to cold shock. We find that the metabolic sensor peroxisome proliferator-activated receptor gamma (PPARγ) is highly expressed in ILC2s of the lung and adipose tissue and increases responsiveness to IL-33. In turn, activation of ILC2 by IL-33 leads to increased expression of PPARγ, a prerequisite for proliferation and expression of the effector cytokines IL-5 and IL-13. In contrast, pharmacological inhibition of PPARγ leads to decreased expression of CD36 and fatty acid uptake, a necessary source of energy for ILC2s and of potential ligands for PPARγ. As a consequence, treatment of mice with a PPARγ antagonist reduces the severity of an ILC2-dependent acute airway inflammation. Together, our results demonstrate the critical role of the metabolic sensor PPARγ for the functions of ILC2s.
Comment in
-
The devil's in the detail: cell-specific role of PPARγ in ILC2 activation by IL-33.Mucosal Immunol. 2021 May;14(3):544-546. doi: 10.1038/s41385-020-00363-6. Epub 2020 Dec 16. Mucosal Immunol. 2021. PMID: 33328594 No abstract available.
-
Turning on ILC2s: diet control.Immunol Cell Biol. 2021 Apr;99(4):344-347. doi: 10.1111/imcb.12429. Epub 2020 Dec 22. Immunol Cell Biol. 2021. PMID: 33354805
References
-
- Gilardi, F. et al. Systemic PPARγ deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility. Metab. Clin. Exp. 95, 8–20 (2019). - DOI
-
- Bouhlel, M. A. et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. 6, 137–143 https://doi.org/10.1016/j.cmet.2007.06.010 (2007).
-
- Nobs, S. P. et al. PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. J. Exp. Med. 214, 3015–3035 (2017). - DOI
-
- Chen, T. et al. PPAR-γ promotes type 2 immune responses in allergy and nematode infection. Sci. Immunol. 2, eaal5196 (2017). - DOI
-
- Klotz, L. et al. The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 206, 2079–2089 (2009). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials